SO
ANRO icon

STRS Ohio’s Alto Neuroscience ANRO Stock Holding History

STRS Ohio’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8K Buy
+600
New +$13.9K ﹤0.01% 2125
2024
Q3 		– Sell
-1,600
Closed -$17.1K – 2088
2024
Q2 		$17.1K Buy
+1,600
New +$20.8K ﹤0.01% 1900

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

STRS Ohio's ANRO Position: Q2 2026 in Review

STRS Ohio opened a new position in Alto Neuroscience (ANRO) in Q2 2026: 600 shares worth $15.8K. The stake represents ﹤0.01% of the portfolio and ranks #2125 among its holdings. This is a return to the name: STRS Ohio previously reported a position in ANRO as recently as Q2 2024.

STRS Ohio first reported a position in ANRO in Q2 2024 and has held it in 2 quarters since. The position peaked at $17.1K in Q2 2024. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • STRS Ohio held 600 shares of Alto Neuroscience worth $15.8K as of Q2 2026.
  • Alto Neuroscience was a new STRS Ohio position in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2125 holding.
  • STRS Ohio first reported a position in Alto Neuroscience in Q2 2024 and has held it in 2 quarters since.
  • STRS Ohio's Alto Neuroscience position peaked at $17.1K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.